Company / CapEx per Share
Inhibrx Biosciences, Inc. CapEx per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.39
FY2023-FY2025
Trend
-97.8%
vs FY2024
Sector context
#161 of 192
Health Care
What the data says
Inhibrx Biosciences, Inc.'s capex per share of $0.00 is lower than 84% of companies in the Health Care sector (FY2025). Declined from $0.39 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025.
Declined from $0.39 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 192This company $0.00 Sector average $3.54
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 97.8% year-over-year.
- Ranks #161 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -97.8% |
| FY2024 | $0.10 | -75.1% |
| FY2023 | $0.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026